Show simple item record

AuthorR, Hephzibah Cathryn
AuthorDatta, Ankur
AuthorS, Udhaya Kumar
AuthorZayed, Hatem
AuthorD, Thirumal Kumar
AuthorC, George Priya Doss
Available date2024-10-28T10:44:13Z
Publication Date2024
Publication NameAdvances in Protein Chemistry and Structural Biology
ResourceScopus
ISSN18761623
URIhttp://dx.doi.org/10.1016/bs.apcsb.2023.12.008
URIhttp://hdl.handle.net/10576/60631
AbstractMotor Neuron Disorders (MNDs), characterized by the degradation and loss of function of motor neurons, are recognized as fatal conditions with limited treatment options and no known cure. The present study aimed to identify the pathophysiological functions and affected genes in patients with MNDs, specifically Amyotrophic Lateral Sclerosis (ALS) and Primary Lateral Sclerosis (PLS). The GSE56808 dataset comprised three sample groups: six patients diagnosed with ALS (GSM1369650, GSM1369652, GSM1369654, GSM1369656, GSM1369657, GSM1369658), five patients diagnosed with PLS (GSM1369648, GSM1369649, GSM1369653, GSM1369655, GSM1369659), and six normal controls (GSM1369642, GSM1369643, GSM1369644, GSM1369645, GSM1369646, and GSM1369647). The application of computational analysis of microarray gene expression profiles enabled us to identify 346 significantly differentially expressed genes (DEGs), 169 genes for the ALS sample study, and 177 genes for the PLS sample study. Enrichment was carried out using MCODE, a Cytoscape plugin. Functional annotation of DEGs was carried out via ClueGO/CluePedia (v2.5.9) and further validated via the DAVID database. NRP2, SEMA3D, ROBO3 and, CACNB1, CACNG2 genes were identified as the gene of interest for ALS and PLS sample groups, respectively. Axonal guidance (GO:0007411) and calcium ion transmembrane transport (GO:0070588) were identified to be some of the significantly dysregulated gene ontology (GO) terms, with arrhythmogenic right ventricular cardiomyopathy (KEGG:05412) to be the top relevant KEGG pathway which is affected in MND patients. ROBO3 gene was observed to have distinctive roles in ALS and PLS-affected patients, hinting towards the differential progression of ALS from PLS. The insights derived from our comprehensive analysis accentuate the distinct variances in the underlying molecular pathogenesis of ALS and PLS. Further research should investigate the mechanistic roles of the identified DEGs and molecular pathways, leading to potential targeted therapies for ALS and PLS.
SponsorThe authors would like to thank the management of the Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, India, and Qatar University, Qatar, for providing the necessary facilities and encouragement to carry out this work. No funding agency was involved in the present study. AD, HCR, UKS, TKD, and GPDC were involved in the study design. AD, HCR, UKS, TKD, and HZ were involved in acquiring, analyzing, interpreting the results, and drafting the manuscript. GPDC supervised the entire study and edited the manuscript. All authors edited and approved the submitted version of the article. The authors declare that the study has no conflict of interest.
Languageen
PublisherElsevier
SubjectAmyotrophic lateral sclerosis
Functional enrichment
Gene networking
Motor neuron disorders
Primary lateral sclerosis
TitleDecoding genetic and pathophysiological mechanisms in amyotrophic lateral sclerosis and primary lateral sclerosis: A comparative study of differentially expressed genes and implicated pathways in motor neuron disorders
TypeArticle
Pagination177-201
Volume Number141
dc.accessType Abstract Only


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record